Outspoken Oncology

Has medical education evolved over the years? Adam Cifu, MD, distinguished educator and mentor in evidence-based medicine, converses with Chadi on why there is a pressing need to evaluate how current and future physicians are being educated.

Chadi Nabhan makes his rounds at the European Hematology Association Annual Meeting and the International Conference on Malignant Lymphoma, interviewing guests such as Elias Jabbour, Kim Linton, and Stefano Luminari.

Vinay Prasad, MD, MPH, policy research and oncologist, dissects with Chadi the theory of "value-based care." How can this concept be used as a tool to better patient care and lower the cost of cancer therapies? Are current value estimations useful in this space? Dr Prasad's podcast "Plenary Session" can be found at vinayakkprasad.com/plenarysession.

Patients and their treating oncologists are faced with many challenges today, including rising drug prices and the opioid crisis, as well as clinical pathway optimization and algorithms to furthering community oncology engagement in clinical research. To discuss it all, Chadi sat down with Clifford Hudis, MD, FACP, FASCO, chief executive officer of ASCO, at the recent ASCO annual meeting. In this one-on-one interview, Dr Hudis shares his views and describes how ASCO is working to optimize care delivery for patients amid these challenges in oncology care.

Bishal Gyawali, MD, PhD, global oncologist and policy researcher, explains to Chadi the financial toxicity faced by patients with cancer and potential strategies to mitigate it. What can be done to “avoid wisely” low-value practices?

Eric Topol, MD, a cardiologist, best-selling author, and entrepreneur, sits down with Chadi to discuss how AI can impact current and future patient care. Chadi explores various aspects of Topol’s recent book, “Deep Medicine,” which comprehensively evaluates the pros and cons of AI in health care.

Chadi sits down with Alison Bateman-House, PhD, MPH, MA, to discuss the details of the Right To Try Act a year after it was signed into law. Was it a good idea? Do patients stand to benefit? What led to this initiative and how does this help clinical trial enrollment, if at all?

Best selling author, researcher, scientist, and world-renowned physician Siddhartha Mukherjee joins Chadi to discuss his career path, what led him to write the inspiring book "The Emperor of All Maladies: A Biography of Cancer," and how his writing impacted his practice and vice versa.

At the 2019 AUA meeting, Chadi led a good-natured debate on PSA screening, open vs robotic surgery, and health supplements with two prominent urologic oncologists: Scott Eggener, MD, University of Chicago, and Ben Davies, MD, University of Pittsburgh.

What happens when an oncologist who dedicated his life to treating cancer is diagnosed with cancer himself? How does this diagnosis shape his life and how he cares for patients? In this heart-to-heart conversation, David Steensma, MD, opens up to Chadi Nabhan, MD, MBA, FACP, as they discuss the human journey of an oncologist dealing with cancer.

Chadi Nabhan, MD, MBA, FACP, and Linda Girgis, MD, a family medicine doctor in New Jersey, discuss a few of the important points of contention for primary care physicians today, including anti-vaccine campaigns, medical exams for certification, and EMR inefficiencies.

Chadi Nabhan, MD, MBA, FACP, makes his rounds at the Summit on National and Global Cancer Health Disparities, interviewing guests such as Clifford Hudis, Otis Brawley, Edith Mitchell, and Ken Anderson.

Chadi Nabhan, MD, MBA, FACP, and Anirban Maitra, MD, director of pancreatic cancer research, The University of Texas MD Anderson Cancer Center, break down important touch points of screening in pancreatic cancer. They also discuss future research topics in adjuvant and metastatic setting and funding opportunities for junior investigators.

Chadi Nabhan, MD, MBA, FACP, and Elaine Schattner, MD, MA, a breast cancer survivor, patient advocate, and former oncologist, breaks down the role of patient advocates in the ever-changing oncology treatment landscape. It is the advocates’ responsibility to educate patients about their treatment options through bias-free therapy information, she argues.

Chadi Nabhan, MD, MBA, FACP, and Laurie Gordon, MD, dig into the extent of the clinician and health care provider burnout "crisis" in America. Localizing burnout in the individual is controversial because burnout is more of a system failure, Dr Gordon argues.